SDF-1α and BMP-2 cotreatment enhanced odontogenic differentiation-related gene and protein expression in vitro and promoted odontogenic differentiation of SCAP in vivo [41]. This evidence concerns the gene BMP2 and syringocystadenoma papilliferum.